Stocks · News reference

Glucotrack shares are trading lower. The company announced its subsidiary Lōkahi Therapeutics will partner with Pepperdine E2B to engage students in its ai2 Pipeline initiative during the upcoming academic year.

Sep 25, 2026, 2:11 PMBenzinga Newsdesk

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Sep 25, 2026, 2:11 PM
Checked: Sep 25, 2026, 2:11 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 30, 2026, 1:09 PMBenzinga Newsdesk
Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes
GCTK
SEC EDGARSep 28, 2026, 9:29 PMSEC EDGAR
8-K filing — Glucotrack, Inc. (GCTK)
Filed: 2026-09-28 AccNo: 0001493152-26-044657 Size: 334 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
GCTK
BenzingaSep 25, 2026, 1:02 PMBenzinga Newsdesk
Glucotrack's Lōkahi Therapeutics Announces Partnership With Pepperdine Business School For MBA Students To Evaluate Drug Assets
GCTK